Loading market dashboard
Argent BioPharma Limited
RGT.LHealthcareLSE
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Argent BioPharma Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Jun 2026 | $25.17M | $25.17M - $25.17M | -$25.17M | -$20.802 | 1 |
| Jun 2025 | $19.87M | $19.87M - $19.87M | -$19.87M | -$41.603 | 1 |
| Jun 2024 | $12.99M | $12.99M - $12.99M | -$12.99M | -$69.946 | 1 |
| Jun 2023 | $4.08M | $4.08M - $4.08M | -$4.08M | -$5.603 | 1 |
| Jun 2022 | $5.60M | $5.60M - $5.60M | -$5.60M | -$2.098 | 1 |
| Jun 2021 | $1.46M | $1.46M - $1.46M | -$1.46M | -$3.043 | 1 |
| Jun 2020 | $1.34M | $1.34M - $1.34M | -$1.34M | -$3.288 | 1 |
| Jun 2019 | $791.5K | $791.5K - $791.5K | -$791.5K | -$2.261 | 1 |
| Jun 2018 | $167.0K | $167.0K - $167.0K | -$167.0K | -$3.917 | 1 |